Sarcomeric protein mutations in dilated cardiomyopathy

Area of Science:

• Cardiology
• Molecular Biology
• Genetics

Background:

• Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
• Genetic factors play a crucial role in the pathogenesis of DCM.
• Mutations in sarcomere and cytoskeleton proteins are increasingly recognized as key contributors to DCM.

Purpose of the Study:

• To review and summarize known mutations in sarcomere and cytoskeleton proteins associated with DCM.
• To discuss the functional consequences of these mutations based on available studies.
• To explore the relationship between mutation effects and protein structure.

Main Methods:

• Literature review of studies reporting DCM-associated mutations.
• Analysis of functional studies investigating the impact of identified mutations.
• Correlation of mutation effects with the structural context of affected proteins.

Main Results:

• Identified mutations in key sarcomere proteins including beta-myosin heavy chain (beta-MHC), myosin binding protein-C (MyBP-C), actin, alpha- tropomyosin (Tm), troponin T (TnT), troponin I (TnI), and troponin C (TnC).
• Reviewed mutations in cytoskeletal proteins such as titin, T-cap, desmin, vinculin, and muscle LIM protein (MLP).
• Highlighted the diverse effects of these mutations on protein function and cardiac muscle mechanics.

Conclusions:

• A wide spectrum of mutations in sarcomere and cytoskeleton proteins are associated with DCM.
• The precise mechanisms by which these mutations lead to DCM remain incompletely understood.
• Shared pathogenic mechanisms may underlie DCM caused by mutations in diverse cardiac structural proteins.